Bypass method alone does not improve insulin resistance

Oct 29, 2010
Patrick Tso, PhD

(PhysOrg.com) -- Bypass weight-loss surgeries do not improve insulin resistance independent of weight loss, say researchers from the University of Cincinnati (UC).

"These findings should raise caution regarding the clinical investigation of duodenal bypass as a surgical or interventional treatment for type 2 …,” the authors say.

Results of the study, led by senior author Patrick Tso, PhD, of UC’s pathology and laboratory medicine department, and Tammy Kindel, MD, now at Northwestern University, are reported in the Oct. 28, 2010, advanced online publication of the journal Obesity.

Surgical procedures like the Roux-en-y gastric bypass (RYGB) include bypassing the top and middle sections of the intestine (the duodenum and jejunum). These procedures have been associated with weight loss and improvement in insulin resistance, a precursor to occurring when insulin is produced but not used properly by the body.

"There are compelling data that RYGB may improve insulin resistance beyond that which can be explained by surgical weight loss,” the authors say.

For their study, Kindel and Tso performed duodenal-jejunal bypass (DJB) on animal models with diet-induced obesity, glucose intolerance and insulin sensitivity. DJB is a modification of RYGB that does not include gastric restriction. With the stomach capacity left preserved, weight loss would not be expected after surgery and changes in could be tested independent of body weight alteration.

The UC study suggests that improved insulin sensitivity, which often follows RYGB, may be linked directly to a reduction in caloric intake or to the surgery’s exclusion of the stomach with possible changes in endocrine signaling

The authors say further investigation is needed to determine the procedure’s efficacy on glucose tolerance.

Explore further: Neutralising antibodies for safer organ transplants

Related Stories

Why can surgical treatment improve type 2 diabetes mellitus?

May 12, 2010

Roux-en-Y gastric bypass (RYGB) is a commonly used surgical treatment for patients with morbid obesity. It significantly and persistently decreases the levels of blood glucose and glycosylated hemoglobin in 80-100 percent ...

Be Aware of Blood Sugar Post Gastric Bypass

Jan 04, 2010

(PhysOrg.com) -- People with type 2 diabetes who have gastric bypass surgery often leave the hospital without the need for previously prescribed diabetes medications.

Gastric bypass surgery increases risk of kidney stones

Mar 10, 2010

March 11, 2010 - Patients who undergo gastric bypass surgery experience changes in their urine composition that increase their risk of developing kidney stones, research from UT Southwestern Medical Center investigators suggests.

Recommended for you

Neutralising antibodies for safer organ transplants

16 hours ago

Serious complications can arise following kidney transplants. If dialysis is required within the first seven days, then the transplanted organ is said to have a Delayed Graft Function (DGF), and essentially ...

User comments : 0